Phage therapy
Document de presse
2021.01.19
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the results of tests, in two preclinical...
Document de presse
2020.08.12
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of...
Document de presse
2020.07.15
Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the individual management and prognosis of...
News
2020.07.06
Infections in humans caused by the hepatitis B virus (HBV) represent a major public health problem. Despite the availability of effective protective vaccines,...
News
2020.06.22
Alzheimer's and Parkinson's diseases are the most widespread forms of neurodegeneration in humans. Each year, 225,000 new cases of Alzheimer's disease are...
News
2020.06.10
An international study has demonstrated that the microbiota and the intestinal cell death triggered by chemotherapy stimulate the efficacy of the immune...
News
2020.05.14
The LuLISA (Luciferase-Linked ImmunoSorbent Assay) research project aims developing high throughput serological tests for epidemiological studies at local,...
Document de presse
2020.04.30
An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes, Icahn School of Medicine at Mount Sinai...
News
2020.04.22
Institut Pasteur partner InovAND, the Excellence Center in the Greater Paris region specializing in autism spectrum and neurodevelopmental disorders, is...
Portrait
2020.03.05
The World Health Organization estimates that more than 5% of the world's population – some 466 million people – are affected by disabling hearing loss.
Recent...